There are 61 (9%) feminine urologist enrolled at Sociedad Colombiana de Urología. 41 (40%) of urology residentes in Colombia are ladies. The purpose of this examine is to exhibit the work tendencies of feminine urologist, feminine residents and affected person’s preferences relating to the gender of their urologist. MATERIALS AND METHODS: Descriptive observational sectional examine with nameless surveys carried out to working towards feminine urologists, feminine residents, and sufferers.
The questions evaluated the demographic traits of the surveyed people; the questions for feminine urologists evaluated their work tendencies; for the residents we evaluated their plans as urologists; and the sufferers have been requested about their preferences to be evaluated in medical session and to have a surgical procedure carried out by both a male or feminine urologist. RESULTS: The survey was answered by 53 feminine urologists.
The common age was 37 years, the bulk (54%) labored in Bogotá. 34% have subspecialized, the bulk in andrology (16%) endourology (16%) and pediatric urology (16%). Most of them (73.6%) carry out surgical procedure between 5-20 hours weekly, and essentially the most carried out surgical procedure was varicocelectomy. 34% referred to have been harassed of their work surroundings based mostly on their gender.Thirty-six feminine residents answered the survey. Th eaverage age was 28 years.
The common variety of tutorial publications was 3. 80% want to obtain a sub-specialization, of which 24% would do it in endourology. 41% referred to have been harassed. 188 sufferers answered the survey, 96 males and 87 ladies; 44.1% most well-liked to be attended in medical session by a feminine urologist, and 49.2% most well-liked to be operated by a male urologist. CONCLUSIONS: The variety of feminine urologists has exponentially elevated, simply as the share of feminine residents. Feminine residents want to subspecialize in various areas. Sufferers desire to be attended by a feminine urologist in medical session however desire to have surgical procedure carried out by a male urologist.
Microbiome research in urology– the place will we stand and the place can we attain?
The position of microbiome milieu within the urinary tract, their interaction in various urological circumstances and their therapeutic implications should not utterly understood. The microbiome has contributed in the direction of urinary tract infections, urolithiasis and urological cancers. The potential of manipulating microbiome for prognosis and remedy is evolving. Probiotics would possibly assist in overcoming the issues of recurrent an infection and antibiotic resistance.
Novel purposes like stents and catheters coated with non-pathogenic organisms are being developed. Analysis within the urinary microbiome has progressed from utilizing mouse fashions to the presently out there three- dimensional cultured organoids, thus making it extra possible. As our information relating to the urinary microbiome will increase, justice might be carried out to many sufferers in whom the developments can be utilized for prophylaxis, prognosis, remedy and even in enhancing their high quality of life.
The rising quantity of antibiotic resistance can be a matter of concern and probiotics is perhaps the reply to this upcoming calamity. On this assessment, we’ve mentioned the position of the urinary microbiome in pathogenesis, prognosis and remedy of urological circumstances and contemplated upon its future prospects.

Way of life in urology: Benign illnesses
Modifiable lifestyle-related threat elements are the thing of accelerating consideration, with a view to main and tertiary prevention, to restrict the onset and improvement of illnesses.Additionally within the urological area there may be accumulating proof of the connection between urological illnesses and lifestyle-related threat elements that may affect their incidence and prognosis.
Danger elements resembling diet, bodily exercise, sexual habits, tobacco smoking, or alcohol consumption might be modified to restrict morbidity and scale back the social impression and the burdensome prices related to prognosis and remedy.
This assessment synthesizes the present scientific proof out there on this subject, attempting to fulfill the necessity for a abstract on the relationships between crucial way of life elements and the primary benign urological illnesses, specializing in benign prostatic hyperplasia (BPH), infections urinary tract (UTI), urinary incontinence (UI), stones, erectile dysfunction, and male infertility.
COVID-19 in european urology : Which classes have we realized?
The coronavirus has challenged all medical methods worldwide. Herein each waves of COVID-19 (coronavirus illness 2019) in spring and autumn 2020 differ principally. Whereas Europe was hit by the primary wave roughly unprepared, which was aggravated by the excessive virulence of COVID-19, the second wave is characterised by a a lot larger contagiosity of the virus with very excessive incidences.
However the virus has attenuated, which is mirrored by the considerably decrease incidence-related mortality fee. Nonetheless, the general rising variety of contaminated sufferers represents once more an important problem for the medical administration of the illness. France and Spain are doing higher compared to Germany and Italy this time.
Absolutely the variety of deaths per week is larger than throughout the peak of the primary wave. Nonetheless, urologists in these nations have additionally skilled better restrictions of their actions within the second shutdown than in Germany, the place there may be solely a discount of beds to between 75 and 90%.
Largely all ranges are operated. Of significance for Germany, nevertheless, is the plateau on a excessive degree for a number of weeks most likely because of the decreased efficacy of a lightweight lock-down. This lastly resulted in a complete lock-down in mid-December 2020. Subsequently in Germany some hospitals are additionally reaching their limits with related penalties for the departments of urology going through a 50% discount of beds and working solely degree III and IV indications.
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-b-48T |
DL Develop |
48T |
EUR 547 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-b-96T |
DL Develop |
96T |
EUR 715 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-c-48T |
DL Develop |
48T |
EUR 527 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-c-96T |
DL Develop |
96T |
EUR 688 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Hu-48T |
DL Develop |
48T |
EUR 380 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Hu-96T |
DL Develop |
96T |
EUR 485 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-p-48T |
DL Develop |
48T |
EUR 547 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-p-96T |
DL Develop |
96T |
EUR 715 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Ra-48T |
DL Develop |
48T |
EUR 508 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
DLR-LIF-Ra-96T |
DL Develop |
96T |
EUR 661 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 555 |
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 771 |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 533 |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 740 |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 367 |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 502 |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 555 |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 771 |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 511 |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
RD-LIF-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 709 |
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 580 |
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 807 |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 557 |
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 774 |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 383 |
Human Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 525 |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 580 |
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 807 |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 534 |
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit |
RDR-LIF-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 742 |
Anti-LIF Antibody |
A01400 |
BosterBio |
100ug/vial |
EUR 294 |
Anti-LIF antibody |
STJ29846 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. |
Anti-LIF Antibody |
PA1562 |
BosterBio |
100ug/vial |
EUR 294 |
Anti-LIF Antibody |
PB9036 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-LIF antibody |
STJ96472 |
St John's Laboratory |
200 µl |
EUR 197 |
Description: Rabbit polyclonal to LIF. |
anti- LIF antibody |
FNab09804 |
FN Test |
100µg |
EUR 548.75 |
|
Description: Antibody raised against LIF |
Polyclonal Goat anti-GST α-form |
GST-ANTI-1 |
Detroit R&D |
50 uL |
EUR 280 |
Polyclonal Goat anti-GST μ-form |
GST-ANTI-2 |
Detroit R&D |
50 uL |
EUR 280 |
Polyclonal Goat anti-GST p-form |
GST-ANTI-3 |
Detroit R&D |
50 uL |
EUR 280 |
Mouse LIF shRNA Plasmid |
20-abx971321 |
Abbexa |
|
|
|
Recombinant Mouse LIF Protein |
R01400-1 |
BosterBio |
100ug/vial |
EUR 294 |
Mouse LIF ELISA Kit |
EML0014 |
Abclonal |
96Tests |
EUR 521 |
LIF antibody |
70R-51295 |
Fitzgerald |
100 ul |
EUR 244 |
Description: Purified Polyclonal LIF antibody |
LIF antibody |
70R-6230 |
Fitzgerald |
50 ug |
EUR 467 |
Description: Rabbit polyclonal LIF antibody |
LIF protein |
30R-2771 |
Fitzgerald |
10 ug |
EUR 369 |
Description: Purified recombinant Human LIF protein |
LIF protein |
30R-2772 |
Fitzgerald |
10 ug |
EUR 489 |
Description: Purified recombinant Mouse LIF protein |
LIF antibody |
70R-12299 |
Fitzgerald |
100 ug |
EUR 403 |
Description: Rabbit polyclonal LIF antibody |
LIF antibody |
70R-14100 |
Fitzgerald |
100 ug |
EUR 322 |
Description: Affinity purified Rabbit polyclonal LIF antibody |
LIF Antibody |
1-CSB-PA198481 |
Cusabio |
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
LIF Antibody |
1-CSB-PA012928ESR2HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
LIF Antibody |
1-CSB-PA004761 |
Cusabio |
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
LIF Antibody |
36950-100ul |
SAB |
100ul |
EUR 252 |
LIF Antibody |
25283-100ul |
SAB |
100ul |
EUR 390 |
Human CellExp? LIF, mouse recombinant |
7268-10 |
Biovision |
|
EUR 370 |
Lif ORF Vector (Mouse) (pORF) |
ORF049145 |
ABM |
1.0 ug DNA |
EUR 506 |
Lif ORF Vector (Mouse) (pORF) |
ORF049146 |
ABM |
1.0 ug DNA |
EUR 506 |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102 |
Neuromics |
5 ug |
EUR 435 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-001 |
GenDepot |
1ml |
EUR 339 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-005 |
GenDepot |
5x1ml |
EUR 1193 |
LIF, Mouse Recombinant , 10MIU/ml |
L4501-001 |
GenDepot |
1ml |
EUR 1454 |
Mouse LIF PicoKine ELISA Kit |
EK0580 |
BosterBio |
96 wells |
EUR 425 |
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA). |
ELISA kit for Mouse LIF |
EK5250 |
SAB |
96 tests |
EUR 553 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse LIF in samples from serum, plasma, tissue homogenates and other biological fluids. |
LIF ELISA Kit (Mouse) (OKEH04045) |
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 544 |
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
LIF ELISA Kit (Mouse) (OKBB00760) |
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 505 |
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
LIF Blocking Peptide |
33R-4712 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody, catalog no. 70R-6230 |
LIF, human recombinant |
4923-10 |
Biovision |
|
EUR 305 |
LIF, human recombinant |
4923-1000 |
Biovision |
|
EUR 5705 |
LIF, human recombinant |
4923-50 |
Biovision |
|
EUR 664 |
LIF, murine recombinant |
4924-10 |
Biovision |
|
EUR 370 |
LIF, murine recombinant |
4924-1000 |
Biovision |
|
EUR 6836 |
LIF Polyclonal Antibody |
ABP52838-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
LIF Polyclonal Antibody |
ABP52838-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
LIF Polyclonal Antibody |
ABP52838-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
LIF Blocking Peptide |
20-abx064170 |
Abbexa |
|
|
|
LIF Rabbit pAb |
A1288-100ul |
Abclonal |
100 ul |
EUR 308 |
LIF Rabbit pAb |
A1288-200ul |
Abclonal |
200 ul |
EUR 459 |
LIF Rabbit pAb |
A1288-20ul |
Abclonal |
20 ul |
EUR 183 |
LIF Rabbit pAb |
A1288-50ul |
Abclonal |
50 ul |
EUR 223 |
Polyclonal LIF Antibody |
APR00279G |
Leading Biology |
0.1mg |
EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
Polyclonal LIF Antibody |
APR06696G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
LIF Polyclonal Antibody |
ES3837-100ul |
ELK Biotech |
100ul |
EUR 279 |
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
LIF Polyclonal Antibody |
ES3837-50ul |
ELK Biotech |
50ul |
EUR 207 |
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
LIF Polyclonal Antibody |
41551-100ul |
SAB |
100ul |
EUR 252 |
LIF Polyclonal Antibody |
41551-50ul |
SAB |
50ul |
EUR 187 |
LIF Conjugated Antibody |
C36950 |
SAB |
100ul |
EUR 397 |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-10ug |
Novoprotein |
10ug |
EUR 146 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-1mg |
Novoprotein |
1mg |
EUR 2283 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-500ug |
Novoprotein |
500ug |
EUR 1613 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-50ug |
Novoprotein |
50ug |
EUR 303 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Lif sgRNA CRISPR Lentivector set (Mouse) |
K3872501 |
ABM |
3 x 1.0 ug |
EUR 339 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-1mg |
Abbexa |
1 mg |
EUR 3168 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x10g |
Abbexa |
3x10 µg |
EUR 328 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x2g |
Abbexa |
3x2 µg |
EUR 230 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
20-abx067761 |
Abbexa |
-
EUR 662.00
-
EUR 272.00
-
EUR 2012.00
-
EUR 787.00
-
EUR 481.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
LIF, Leukemia inhibitory factor, murine (mouse) |
RC234-18 |
Bio Basic |
5ug |
EUR 104.38 |
|
Mouse Leukemia inhibitory factor,LIF ELISA kit |
CN-02441M1 |
ChemNorm |
96T |
EUR 467 |
Mouse Leukemia inhibitory factor,LIF ELISA kit |
CN-02441M2 |
ChemNorm |
48T |
EUR 316 |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196578 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196579 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196580 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196581 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196582 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196583 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196584 |
ABM |
500 ng |
EUR 603 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196585 |
ABM |
500 ng |
EUR 603 |
Mouse Leukemia inhibitory factor, LIF ELISA kit |
CSB-E04652m-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Leukemia inhibitory factor, LIF in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse Leukemia inhibitory factor, LIF ELISA kit |
1-CSB-E04652m |
Cusabio |
-
EUR 946.00
-
EUR 5782.00
-
EUR 3060.00
|
-
1 plate of 96 wells
-
10 plates of 96 wells each
-
5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Leukemia inhibitory factor, LIF in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Recombinant Mouse LIF Protein, Untagged, E.coli-100ug |
QP4235-100ug |
EnQuireBio |
100ug |
EUR 608 |
Recombinant Mouse LIF Protein, Untagged, E.coli-1mg |
QP4235-1mg |
EnQuireBio |
1mg |
EUR 2658 |
Recombinant Mouse LIF Protein, Untagged, E.coli-20ug |
QP4235-20ug |
EnQuireBio |
20ug |
EUR 237 |
Recombinant Mouse LIF Protein, Untagged, E.coli-500ug |
QP4235-500ug |
EnQuireBio |
500ug |
EUR 1660 |
Recombinant Mouse LIF Protein, Untagged, E.coli-5ug |
QP4235-5ug |
EnQuireBio |
5ug |
EUR 136 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3872502 |
ABM |
1.0 ug DNA |
EUR 154 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3872503 |
ABM |
1.0 ug DNA |
EUR 154 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3872504 |
ABM |
1.0 ug DNA |
EUR 154 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
4-PAA085Mu01 |
Cloud-Clone |
-
EUR 236.00
-
EUR 2338.00
-
EUR 586.00
-
EUR 294.00
-
EUR 209.00
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
abx574566-96tests |
Abbexa |
96 tests |
EUR 754 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein (Active) |
20-abx655747 |
Abbexa |
-
EUR 857.00
-
EUR 314.00
-
EUR 2750.00
-
EUR 1024.00
-
EUR 592.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
Mouse Leukemia Inhibitory Factor (LIF) CLIA Kit |
abx195395-96tests |
Abbexa |
96 tests |
EUR 825 |
|
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit |
abx254611-96tests |
Abbexa |
96 tests |
EUR 754 |
|
ISOKine-Leukemia Inhibitory Factor (LIF), mouse-NEW |
PR80000 |
Neuromics |
50 ug |
EUR 376 |
Recombinant Mouse LIF/Leukemia inhibitory factor Protein |
RP00544 |
Abclonal |
10 μg |
EUR 174 |
Mouse Leukemia inhibitory factor(LIF)ELISA Kit |
GA-E0658MS-48T |
GenAsia Biotech |
48T |
EUR 336 |
Mouse Leukemia inhibitory factor(LIF)ELISA Kit |
GA-E0658MS-96T |
GenAsia Biotech |
96T |
EUR 534 |
LIF Leukemia Inhibitory Factor Mouse Recombinant Protein |
PROTP09056 |
BosterBio |
Regular: 25ug |
EUR 317 |
Description: Leukemia Inhibitory Factor (LIF) Murine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 181 amino acids and having a molecular mass of 20 kDa. ;The Leukemia Inhibitory Factor (LIF) is purified by proprietary chromatographic techniques. |
Mouse Lif/ Leukemia inhibitory factor ELISA Kit |
E1656Mo |
Sunlong |
1 Kit |
EUR 546 |
Mouse Lif(Leukemia inhibitory factor) ELISA Kit |
EM0237 |
FN Test |
96T |
EUR 567.6 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 46.9pg/ml |
However, the administration of urologic sufferers throughout the COVID-19 pandemic is carried out in Europa on a excessive commonplace. Therefor the danger of secondary hurt to our sufferers is anticipated to be reasonably minimal in the long term.